Centiva Capital’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Centiva Capital’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-422,956	Closed	-$4.18M	–	1811
2022 Q3	$4.18M	Hold	422,956	–	–	0.08%	188
2022 Q2	$4.15M	Buy	422,956 +9,946	+2%	+$97.5K	0.1%	182
2022 Q1	$4.05M	Buy	413,010 +9,614	+2%	+$93.8K	0.08%	225
2021 Q4	$3.93M	Hold	403,396	–	–	0.08%	222
2021 Q3	$3.92M	Hold	403,396	–	–	0.25%	95
2021 Q2	$3.9M	Buy	+403,396	New	+$3.94M	0.09%	177

Centiva Capital's SSAA Position: Q4 2022 in Review

Centiva Capital sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 422,956 shares — an estimated $4.18M sold.

Centiva Capital first reported a position in SSAA in Q2 2021 and held it in 6 quarters. The position peaked at $4.18M in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Centiva Capital reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Centiva Capital sold 422,956 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $4.18M.
Centiva Capital first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 6 quarters.
Centiva Capital's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $4.18M in Q3 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.